A Patient Centered Approach to Hypophosphatemia: Diagnosis, Evaluation, and Treatment

Begin

Learning Objectives:

• Incorporate best practices for evaluating and diagnosing patients with hypophosphatemia in their practice.
• Discuss pathophysiology and treatment strategies for patients with FGF-23 mediated phosphate disorders.
• Discuss pathophysiology and treatment strategies for patients with non-FGF-23 mediated phosphate disorders.

Credits:
2.0 AMA PRA Category 1 Credits™
2.0 ABIM MOC

Meeting The Needs of Patients, Not LDL-C Goals: The Role Of PCSK9 Inhibitors

Begin

Learning Objectives:

• Summarize the biology and genetic underpinnings of dyslipidemia as related to the LDL receptor.
• Discuss and identify lipid lowering therapies beyond traditional therapeutics like statins.
• Recognize the benefit of including PCSK9 inhibitors in the treatment of patients with ASCVD or FH.
• Assess the clinical trial evidence for the efficacy and safety of PCSK9 inhibitors in patients with statin intolerance.
• Review the cardiovascular risk reduction provided by PCSK9 inhibitors in combination with statin therapy.

Credits:
2.0 AMA PRA Category 1 Credits™
2.0 ABIM MOC

Beyond A1C: Type 1 Diabetes Care and Management

Begin

Learning Objectives:

• Devise individualized insulin therapy strategies to manage individuals with T1D
• Incorporate diabetes technology into treatment strategies for appropriate individuals with T1D
• Recognize and evaluate individuals with T1D for signs of microvascular disease
• Apply updated knowledge of treatments, practice guidelines, and clinical skills to improve hypoglycemia prevention and exercise management

Credits:
6.0 AMA PRA Category 1 Credits™
6.0 ABIM MOC

Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• Diagnose central precocious puberty in male childhood cancer survivors exposed to gonadotoxic therapy.
• Explain how GH deficiency and central precocious puberty may occur together, making it difficult to interpret linear growth data.
• Diagnose non–GH-related causes of growth failure such as spinal irradiation.
• Accurately interpret thyroid function tests in patients at risk for primary and central hypothyroidism.
• Explain the importance of the synergistic action of GH and sex hormones in the growing adolescent.
• Explain the risk for exacerbation of the symptoms of adrenal insufficiency in individuals on thyroid replacement and untreated central adrenal insufficiency.

Credits:
0.5 AMA PRA Category 1 Credits™

Endocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• List significant changes in the evidence base for Gender Dysphoria /Gender Incongruence since publication of the previous ES guideline on this topic.
• Define significant changes in best practices that are being recommended in the 2017 Gender Dysphoria/Gender Incongruence guideline due to changes in science.
• Identify gaps in the existing evidence base for Gender Dysphoria /Gender Incongruence which contribute to controversy or disagreement among clinicians about standards for optimal patient care.

Credits:
1.0 ABIM MOC
1.0 ABP MOC
1.0 AMA PRA Category 1 Credits™

Testosterone Treatment of Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• Diagnose androgen deficiency syndromes in men  
• Select appropriate therapeutic options for patients with diagnosed androgen deficiency  
• Effectively manage prescribed therapies for these patients.

Credits:
5.0 ABIM MOC
5.0 AMA PRA Category 1 Credits™

Growth Hormone Deficiency: Diagnosis Challenges and Treatment Considerations

Begin

Learning Objectives:

• Incorporate up to date guideline recommendations when screening and testing for GHD
• Devise treatment strategies that incorporate current knowledge on the safety, risks, and benefits of long-term GH replacement in the management of GHD
• Apply diagnosis criteria and evaluate treatment options for patients with GHD management during the transition into adulthood

Credits:
1.0 ABIM MOC
1.0 AMA PRA Category 1 Credits™

Evaluation & Management Coding Revisions: What You Need to Know

Begin

Learning Objectives:

• Understand potential changes to office visit reimbursement and documentation

Credits:
1.0 AMA PRA Category 1 Credits™

Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline Educational Activity

Begin

Learning Objectives:

• formulate clinical practice guidelines for the treatment of diabetes in
  older adults.

Credits:
1.0 AMA PRA Category 1 Credits™